CLU and Alzheimer disease: Because the size and shape of plaques in the extracellular spaces of the brain do not correlate with the degree of cognitive decline [40], overall, our results suggest that clusterin facilitates the clearance of Aβ along the walls of cerebral arteries and therefore may contribute to in preventing CAA, which is a key pathological feature of AD [41].